Aevice - Personalized Care Reimagined

Our Solutions

A.I. powered wearable stethoscope recording and analyzing lung sounds to detect early signs of chronic respiratory disease exacerbation remotely.

Find Out More

Smart wearable for kids tracking their respiratory rate and heart rate through the night

Find Out More

Learn more about the science behind our technology.

5

Chronic Respiratory Disease is Pervasive and Costly

Asthma

Asthma is a disease causing airways to become inflamed and narrow. It is the most common chronic condition among children.

339M

in the world affected by Asthma².

>US$3K

spent per patient in the USA due to Asthma³.

1,300

deaths per day due to Asthma¹.

>US$3K

spent per patient in the USA due to Asthma³.

14%

of children suffer from Asthma globally¹.

COPD

Chronic Obstructive Pulmonary Disease
(COPD) is a group of diseases that limit airflow to lungs. It is a long-term disease that gradually worsens over time.

210M

in the world affected by COPD⁴.

US$316K

average lifetime earnings losses per individual due to premature retirement⁵.

3rd

leading cause of death by 2030¹.

>72%

underdiagnosed globally¹.

Chronic Respiratory Disease is Difficult to Manage

%

of patients do not consult
the GP despite experiencing
bronchial symptoms⁶.

%

of patients diagnosed with asthma do not adhere to treatment plans⁷.

%

of patients above 65 years old unable to perform a valid spirometry test, complicating COPD diagnoses⁸.

How We Can Help

Our scalable and cost effective patient-centered solutions address unique needs of stakeholders.

Patients

Improve treatment adherence by visualizing response to treatment plan.
Reduce healthcare costs by enabling management of disease from home.
Personalize experience to optimize engagement with healthcare providers.

Pharmaceutical Companies

Provide real-world evidence in drug development and commercialization.
Optimize recruitment and retention for trials through remote data collection.
Increase value-based payments through patient-centred endpoints.

Healthcare Providers

Deliver value-based care with improved patient-reported outcomes.
Increase patient engagement and improve communication.
Streamline diagnosis and treatment for effective and efficient care.

Payers

Reduce readmissions in hospitals and overall healthcare expenditure.
Facilitate self-management of chronic respiratory disease from home.
Drive risk stratification to identify unique needs to personalize patient experience.

Payers

Reduce readmissions in hospitals and overall healthcare expenditure.
Facilitate self-management of chronic respiratory disease from home.
Drive risk stratification to identify unique needs to personalize patient experience.

Healthcare Providers

Deliver value-based care with improved patient-reported outcomes.
Increase patient engagement and improve communication.
Streamline diagnosis and treatment for effective and efficient care.

Partners

Investors

Press & Media

Aevice Health Receives Singapore HSA Approval for First Smart Wearable Stethoscope in Singapore

Singapore, 29 March 2023 – Aevice Health, a Singapore-based MedTech company that specializes in developing remote respiratory monitoring solutions, today announced that its flagship medical device, the AeviceMD Monitoring System, has received approval from the Health Sciences Authority of Singapore (HSA). The award-winning patient management platform… (Read More)

Aevice Health Announces the Appointment of David Van Sickle, Former CEO of Propeller Health, as the Board Advisor

Singapore, 15 September, 2022 – Aevice Health, a MedTech company developing novel wearables to enable remote management of chronic respiratory diseases, is pleased to announce the appointment of David Van Sickle, PhD, as Strategic Advisor. Van Sickle, who served as the co-founder and former CEO of Propeller Health, has over 15 years… (Read More)

Let’s Connect

We’d love to share more about our solutions.

Contact Us

References

Forum of International Respiratory Societies. The Global Impact of Respiratory Disease. 2nd ed. 2017. https://www.who.int/gard/publications/The_Global_Impact_of_Respiratory_Disease.pdf.
World Health Organisation. “Asthma.” 2020. https://www.who.int/news-room/fact-sheets/detail/asthma.
Dierick, Boudewijn J.H., Thys Van Der Molen, Bertine M.J. Flokstra-de Blok, Antonella Muraro, Maarten J. Postma, Janwillem W.H. Kocks, and Job F.M. Van Boven. “Burden and Socioeconomics of Asthma, Allergic Rhinitis, Atopic Dermatitis and Food Allergy.” Expert Review of Pharmacoeconomics & Outcomes Research, 2020, 437-53. doi:10.1080/14737167.2020.1819793.
World Health Organisation. Global Surveillance, Prevention and Control of Chronic Respiratory Diseases: A Comprehensive Approach. 2007. https://www.who.int/gard/publications/GARD Book 2007.pdf?ua=1.
Fletcher, Monica J., Jane Upton, Judith Taylor-Fishwick, Sonia A. Buist, Christine Jenkins, John Hutton, Neil Barnes, Thys Van Der Molen, John W. Walsh, Paul Jones, and Samantha Walker. “COPD Uncovered: An International Survey on the Impact of Chronic Obstructive Pulmonary Disease [COPD] on a Working Age Population.” BMC Public Health, 2011. doi:10.1186/1471-2458-11-612.
Aaron, Shawn D., Louis Phillippe Boulet, Helen K. Reddel, and Andrea S. Gershon. “Underdiagnosis and Overdiagnosis of Asthma.” American Journal of Respiratory and Critical Care Medicine, 2018, 1012-020. doi:10.1164/rccm.201804-0682CI.
Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2020. https://ginasthma.org/wp-content/uploads/2020/04/GINA-2020-full-report_-final-_wms.pdf.
Hangaard, Stine, Tina Helle, Carl Nielsen, and Ole K. Hejlesen. “Causes of Misdiagnosis of Chronic Obstructive Pulmonary Disease: A Systematic Scoping Review.” Respiratory Medicine, 2017, 63-84. doi:10.1016/j.rmed.2017.05.015.